Analyst Ratings February 3, 2026

BofA Moves Oshkosh to Neutral, Points to More Balanced Risk/Reward

Analyst lift follows Q4 results and revised guidance for the cyclical Access unit as valuation risk appears to ease

By Avery Klein OSK
BofA Moves Oshkosh to Neutral, Points to More Balanced Risk/Reward
OSK

BofA Securities raised its rating on Oshkosh Corporation from Underperform to Neutral and set a $149.00 price target, roughly in line with the stock's recent trading level. The upgrade reflects a view that the company’s portfolio is shifting toward steadier profit sources, lower valuation risk and the Access segment being at a trough, even as Oshkosh trimmed guidance for that cyclical unit into 2026.

Key Points

  • BofA Securities upgraded Oshkosh from Underperform to Neutral and set a $149.00 price target, near the recent share price of $149.48 - impacts equity investors and industrials sector sentiment.
  • Analysts cite a positive mix shift toward more stable profit sources and a 6% free cash flow yield, reducing valuation risk - relevant to fixed income and equity valuation assessments.
  • Oshkosh reported Q4 adjusted EPS of $2.26 versus $2.31 expected and revenues of $2.69 billion versus $2.6 billion expected; DA Davidson raised its price target to $168 while keeping a Buy rating.

BofA Securities upgraded Oshkosh (NYSE: OSK) from Underperform to Neutral on Tuesday and assigned a price target of $149.00, a level close to the stock's recent market quote of $149.48. The research note said the firm sees the company's risk/reward profile as more balanced after the latest results and guidance.

The firm pointed to a "positive mix shift" across Oshkosh's business, with a growing share of profits coming from more stable segments. BofA also cited a 6% free cash flow yield and the Access division appearing to have reached trough levels as reasons why valuation risk has eased.

Oshkosh reported fourth-quarter 2025 adjusted earnings per share of $2.26, slightly below analysts' consensus of $2.31. Revenue for the quarter came in at $2.69 billion, beating the expected $2.6 billion. Following those results, DA Davidson raised its price objective to $168 from $160 while keeping a Buy rating, noting that Oshkosh's 2026 outlook seemed "admittedly light."

BofA's upgrade follows the company lowering guidance again for its cyclical Access unit for 2026. The brokerage characterized the revised outlook as reflecting "an appropriately balanced view on construction," a position the firm believes limits further downside risk to the shares.

Other data referenced by analysts indicate Oshkosh has produced strong shareholder returns, with a 34.8% gain over the past year, and that the company carries a moderate level of debt. BofA acknowledged that some risks to earnings per share remain, but concluded that the overall reward potential relative to downside risk has improved enough to support the rating change.

The mix shift toward steadier businesses, the company’s free cash flow profile and the Access segment hitting trough levels were central to BofA's assessment. At the same time, the shortfall versus EPS expectations in the quarter and the lowered guidance for Access underline areas of ongoing uncertainty.

Investors and market participants will likely watch Oshkosh's 2026 guidance and execution closely to see whether the company can sustain revenue momentum and convert improved cash generation into durable valuation support.

Risks

  • Ongoing downside risk to earnings per share remains despite the upgrade, which could affect investor returns and equity valuations in the industrials sector.
  • The Access unit was guided down again for 2026 and remains cyclical, exposing Oshkosh to construction activity cycles and related market volatility.
  • Quarterly results showed EPS below expectations, indicating execution or margin pressures that could influence near-term stock performance and analyst estimates.

More from Analyst Ratings

GLJ Research Lowers Daqo New Energy to Sell, Sets $18.13 Target Feb 3, 2026 JPMorgan Sticks With Overweight on Disney Despite Near-Term Earnings Questions Feb 3, 2026 Canaccord Lifts WAVE Life Sciences Price Target to $43 After Regaining WVE-006 Rights Feb 3, 2026 Acadia Shares Slip After CHMP Signals Negative Vote on Trofinetide Marketing Application Feb 3, 2026 Canaccord Cuts Roblox Price Target to $140 Citing Margin Pressure as Engagement Rises Feb 3, 2026